What is the treatment for onychomycosis in an 18-month-old child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Onychomycosis in an 18-Month-Old Child

For an 18-month-old child with onychomycosis, oral terbinafine is the first-line treatment at a dose of 62.5 mg per day if weight is <20 kg for 6 weeks for fingernail infection and 12 weeks for toenail infection. 1

First-Line Systemic Therapy Options

  • Terbinafine: First-line treatment for dermatophyte onychomycosis in children and generally preferred over itraconazole 1

    • Dosage: 62.5 mg per day if weight is <20 kg, 125 mg per day for 20-40 kg weight 1
    • Duration: 6 weeks for fingernail infection, 12 weeks for toenail infection 1
    • Monitoring: Baseline liver function tests and complete blood count recommended as it is unlicensed for use in children 1
    • Common adverse effects: Headache, taste disturbance, gastrointestinal upset 1
  • Itraconazole: Alternative first-line treatment for dermatophyte onychomycosis 1

    • Dosage: "Pulse therapy" 5 mg/kg per day for 1 week per month 1
    • Duration: Two pulses for fingernails, three pulses for toenails 1
    • Optimally absorbed with food and acidic pH 1
    • Monitoring: Hepatic function tests recommended in patients with pre-existing abnormal results or receiving continuous therapy 1

Second-Line Systemic Therapy Options

  • Fluconazole: Consider if terbinafine and itraconazole are contraindicated or not tolerated 1

    • Dosage: 3-6 mg/kg once weekly 1
    • Duration: 12-16 weeks for fingernail infection, 18-26 weeks for toenail infection 1
    • Monitoring: Baseline liver function tests and full blood count 1
  • Griseofulvin: Consider as second-line if terbinafine and itraconazole are contraindicated 1, 2

    • Dosage: 10 mg/kg per day (for children older than 1 month) 1
    • Not recommended as first-line due to long treatment duration and low efficacy 1
    • Should be taken with fatty food to increase absorption 1

Topical Therapy Considerations

  • Topical therapy may be more effective in children than adults due to their thinner, faster-growing nails 1, 3, 4
  • Consider topical therapy for mild cases or as adjunctive therapy 5
  • Options include:
    • Amorolfine 5% lacquer: Applied once or twice weekly for 6-12 months 1
    • Ciclopirox 8% lacquer: Applied once daily for up to 48 weeks 1
    • Combination of topical and systemic therapy may provide antimicrobial synergy and improved efficacy 1

Important Clinical Considerations

  • Confirm diagnosis through mycological examination before starting treatment 5
  • Examine family members for onychomycosis and tinea pedis as familial disease often occurs 1, 4
  • Check for concomitant tinea capitis and tinea pedis in the affected child 1, 6
  • Children respond better to treatment than adults and show faster response to antifungal therapy 1
  • Recurrence rates may be higher in children than adults, requiring vigilance after treatment 4

Prevention of Recurrence

  • Apply antifungal powders containing miconazole, clotrimazole, or tolnaftate to shoes and feet 1
  • Wear cotton, absorbent socks 1
  • Keep nails short 1
  • Avoid sharing nail clippers with family members 1
  • Consider disinfecting or discarding contaminated footwear 1

Despite the limited number of clinical trials specifically in very young children, systemic antifungal therapy with terbinafine appears to be the most effective approach with a favorable safety profile for treating onychomycosis in an 18-month-old child 1, 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Antifungal therapy for onychomycosis in children.

Clinics in dermatology, 2015

Research

Pediatric Onychomycosis: The Emerging Role of Topical Therapy.

Journal of drugs in dermatology : JDD, 2017

Research

Onychomycosis in children - review on treatment and management strategies.

The Journal of dermatological treatment, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.